Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?
OBJECTIVE
The aim of this study was to determine whether genetic variation at the cannabinoid receptor-1 (CNR1) locus could have an effect on adiposity, fat distribution and obesity-related metabolic disorders in Polish postmenopausal women.


METHODS
The A3813G (rs12720071), G1422A (rs1049353), A4895G (rs806368) and rs806381, rs10485170, rs6454674 and rs2023239 single-nucleotide polymorphisms of CNR1 were genotyped in 348 randomly selected postmenopausal women aged 50-60 years recruited from the Wroclaw city population.


METHODS
CNR1 genotypes, anthropometric measures (body mass index (BMI), waist circumference (WC) and body fat distribution by dual energy X-ray absorptiometry) and metabolic parameters (glucose, lipid profile and Fasting Insulin Resistance Index for insulin resistance) were determined.


RESULTS
The 3813G allele was not significantly associated with higher body mass, BMI, WC, total fat or fat percentage, but was associated with higher android fat deposit (2971.78±1655.08 vs 2472.64±1300.53, P=0.007) and percentage of android fat (37.59±8.45 vs 35.66±7.63, P=0.062). No associations for the G1422A, A4895G, rs806381, rs10485170, rs6454674 and rs2023239 variants were observed.


CONCLUSIONS
There is an association of the variants of CNR1 with obesity-related phenotypes in Polish postmenopausal women. As cannabinoid receptor type 1 is a drug target for obesity, pharmacogenetic receptor gene analysis of obesity treatment by endocannabinoid blockade may be of interest to identify the best responders.
Milewicz
A
A
Department of Endocrinology, Diabetology and Isotope Treatment, Wroclaw Medical University, Wroclaw, Poland.
Tworowska-Bardzińska
U
U
Jędrzejuk
D
D
Lwow
F
F
Dunajska
K
K
Łaczmański
Ł
Ł
Pawlak
M
M
D050154:Adiposity / Q000235:genetics* / Q000502:physiology; D050218:Body Fat Distribution; D015992:Body Mass Index; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006801:Humans; D024821:Metabolic Syndrome / Q000235:genetics* / Q000503:physiopathology; D008875:Middle Aged; D009765:Obesity / Q000235:genetics* / Q000503:physiopathology; D011044:Poland; D011110:Polymorphism, Genetic / Q000235:genetics; D017698:Postmenopause; D043884:Receptor, Cannabinoid, CB1 / Q000235:genetics*
D043884:Receptor, Cannabinoid, CB1